Product Information
PT2399 is a molecule that is structurally related to the fatty acid ursolic acid. It has been shown to inhibit the growth of various human carcinoma cell lines in vitro and in vivo. PT2399 has also been shown to induce apoptosis in cancer cells, thereby reducing tumour size. The safety profile of PT2399 is favourable with no significant side effects observed at doses up to 1000 mg/kg body weight. PT2399 also shows efficacy against stromal tumours, which are typically resistant to most chemotherapeutic agents.
Chemical properties
Technical inquiry about: 3D-XRC66214 PT2399
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
